Preview

Нефрология

Расширенный поиск

ДИСФУНКЦИЯ ЭНДОТЕЛИЯ У ПАЦИЕНТОВ С ПРОГРЕССИРУЮЩИМИ ЗАБОЛЕВАНИЯМИ ПОЧЕК

https://doi.org/10.24884/1561-6274-2005-9-2-16-22

Полный текст:

Аннотация

Дисфункция эндотелия у пациентов с прогрессирующими заболеваниями почек.

Об авторах

А. Н. Шишкин
Санкт-Петербургский государственный университет
Россия

Кафедра терапии, медицинский факультет



Д. В. Кирилюк
Санкт-Петербургский государственный университет
Россия

Кафедра терапии, медицинский факультет



Список литературы

1. Петрищев НН, Власов ТД. Физиология и патофизиология эндотелия. В: Петрищев НН, ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. Изд.во СПбГМУ, 2003; 437

2. Klahr, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 18:165766

3. Цатурян ВВ. Дисфункция эндотелия и ее взаимосвязь с другими факторами риска сосудистых осложнений у больных сахарным диабетом типа 2. Автореф. дисс. на соиск.к.м.н., СПб, 2004: 24

4. Семидоцкая ЖД. Эндотелиальная дисфункция у пациентов с хроническим гломерулонефритом. Актуальные проблемы экстракорпорального очищения крови, нефро логии и гемафереза. Сб мат Первого объединенного конгресса. М, 2002: 37

5. Harris RC. Cycloxygenase2 in the kidney. J Am Soc Nephrol 2000; 11: 23872394

6. Border WA, Noble NA. Transforming growth factorbeta in tissue fibrosis. N Engl J Med 1994; 12861292

7. Shankland SJ, Wolf G. Cell cycle regulatory proteins in renal disease: Role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000; 278: F515F529

8. Sugiyama H, Kashihara N, Makino H et al. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103111

9. Savill J, Mooney A, Hughes J. Apoptosis and renal scarring. Kidney Int Suppl 1996; 54: S1417 10. Suga SI, Phillips MI, Ray PE et al. Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. Am J Physiol Renal Physiol 2001; 281: F620 F629

10. Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int 1998; 65: S74S78

11. Anderson S, Brenner BM. Therapeutic effect of converting en-zyme inhibition in progressive renal disease. Am J Hypertens 1988; 1: 380S383S

12. Marcussen N, Nyengaard J, Christensen S. Compensatory growth of glomeruli is accomplished by an increased number of glomerular capillaries. Lab Invest 1994; 70: 868874

13. Shimizu A, Kitamura H, Masuca Y et al. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol 1997; 151: 12311239

14. Kitamura H, Shimizu A, Masuda Y et al. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant kidney model. Exp Nephrol 1998; 6: 328336

15. Bohle A, MackensenHaen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996; 19: 191 195

16. Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 2000; 11: 4756

17. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794814

18. Frazier W. Thrombospondins. Curr Opin Cell Biol 1991; 3: 792799

19. Yevdokimova N, Wahab NA, Mason R. Thrombospondin 1 is the key activator of TGF31 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 2001; 12: 703712

20. Kupprion C, Matamed K, Sage EH. SPARC (BM 40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 1998; 273: 2963529640

21. Bassuk J, Pichler R, Rothmeier JD et al. Induction of TGFj3 by the matricellular protein SPARC in a rat model of glomerulonephritis. Kidney Int 2000; 51: 117128

22. Soker S, GollamudiPayne S, Fidder H et al. Inhibition of vascular endothelial growth factor (VEGF)induced endothelial cell proliferation by a peptide corresponding to the exon 7encoded domain of VEGF 165. Biol Chem 1997; 272: 3158231588

23. Thomas S, Vanuystel J, Gruden G et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 2000; 11: 12361243

24. Kanellis J, Fraser S, Katerelos M, Power DA. Vascular endothe-lial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 2000; 278: F905 F915

25. Gengrinovitch S, Berman B, David G et al. Glypican1 is a VEGF 165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem 1999; 274: 1081610822

26. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl2 and Al in vascular endothelial cells. J Biol Chem 1998; 273: 1331313316

27. Kang DH, Anderson S, Kim YG et al. Impaired angiogenesis in the aging kidney: Potential role of VEGF and TSP1 in renal disease. Am J Kid Dis 2001;37: 601611

28. Reed MJ, Corsa A, Pendergrass W et al. Neovascularization in aged mice: delayed angiogenesis is coincident with decreased levels of transforming growth factor betal and type I collagen. Am J Pathol 1998; 152: 113123

29. Kitamoto Y, Tokunaga H, Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development. J Clin Invest 1997; 99: 23512357

30. Epstein FH, Agmon Y, Brezis M. Physiology of renal hypoxia. Ann NY Acad Sci 1994;718: 7281

31. Simon M, Grone HJ, Johren O et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995; 268: F240F250

32. Kang DH, Anderson S, Kim YG, et al. Role of the microvascular endotelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806812

33. Stroes EG, Joles JA, Chang PC, Koomans H. Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 1995; 48: 544550

34. Williams B, Baker A, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995 ; 25: 913917

35. IruelaArispe L, Gordon KL, Hugo C et al. Participation of the glomerular endothelial cell in capillary repair in glomerulonephritis. Am J Pathol 1995; 147: 17151727

36. Ostendorf T, Kunter U, Loos A et al. Vascular endothelial growth factor (VEGF165) mediates glomerular endothelial repair. J Clin Invest 1999; 104: 913923

37. Masuda Y, Shimizu A, Mori T et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001;159: 599608

38. Sunderkotter C, Steinbrink K, Goebeler M et al. Macrophages and angiogenesis J Leukoc Biol 1994; 55: 410 422

39. Erwig LP, Stewart K, Rees AJ. Macrophages from inflamed but not normal glomeruli are unresponsive to anti inflammatory cytokines. Am J Pathol 2000;156: 295301

40. Kang DH, Anderson S, Kim YG et al. Impaired angiogenesis in the remnant kidney model (II): VEGF administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001; 12: 14481457

41. Pillebout E, Burtin M, Yuan HT et al. Proliferation and remodeling of the peritubular microcirculation after nephron reduction. Association with the progression of renal lesions. Am J Pathol 2001; 159: 547560

42. BelloReuss E, Holubec K, Rajaraman S. Angiogenesis in autosomaldominant polycystic kidney disease. Kidney Int 2001; 60: 3745

43. AlNimri MA, Komers R, Oyama TT et al. Endothelial derived vasoactive mediators in polycystic kidney disease. Kidney Int 2003; 63(5):1776 1782

44. Vriese AS, Tilton RG, Elger M et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12: 9931000

45. BreitenederGelef S, Soleiman A, Kowalski J et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker of lymphatic endothelium. Am J Pathol 1999; 154: 385394


Для цитирования:


Шишкин А.Н., Кирилюк Д.В. ДИСФУНКЦИЯ ЭНДОТЕЛИЯ У ПАЦИЕНТОВ С ПРОГРЕССИРУЮЩИМИ ЗАБОЛЕВАНИЯМИ ПОЧЕК. Нефрология. 2005;9(2):16-22. https://doi.org/10.24884/1561-6274-2005-9-2-16-22

For citation:


Shishkin A.N., Kirilyuk D.V. ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH PROGRESSIVE RENAL DISEASE. Nephrology (Saint-Petersburg). 2005;9(2):16-22. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-2-16-22

Просмотров: 47


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)